Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Stay Far Away From Canopy Growth Stock … For Now

By Chris Tyler, InvestorPlace Contributor
Taking the plunge in CGC today could prove a massive mistake, but that’s not to say buying Canopy Growth stock won’t make a worthy investment in the longer term.

Cronos Australia Offers Little Help to Cronos Group Stock

By Will Healy, InvestorPlace Contributor
Cronos Australia could help lend some credibility to Cronos Group, but it appears too small to significantly affect CRON stock.

Wait for the Dust to Settle Before Buying Canopy Growth Stock

By Thomas Niel, InvestorPlace Contributor
CGC stock has fallen 50% since July. But with the pot stock maelstrom just starting, wait for lower prices to buy Canopy Growth stock.

Plunging Tilray Stock Shows Just How Much Sentiment Has Changed

By Vince Martin, InvestorPlace Contributor
Tilray stock keeps falling and now is nearing its IPO price. Trading in TLRY stock shows how much faith investors have lost in pot stocks.

This $2 Billion Cannabis Catalyst Is Just Days Away

By InvestorPlace Research Staff
Cannabis companies are on the verge of ushering in a whole new category of products and welcoming a brand-new group of consumers.

7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk

By Mark Putrino, CMT
Not too long ago, shares of these companies were much higher. Now they are considered marijuana penny stocks. But that's not necessarily a bad thing if you're an investor who's willing to take risks.

HEXO Stock Has Crashed — And It May Drop Even More

By Mark Putrino, CMT
Hexo stock suffered after it withdrew its outlook ahead of its Q4 earnings report. Investors worry this may not be the end.

Canopy Growth Stock Has Gone Up in Smoke

By Nicolas Chahine, InvestorPlace Contributor
The cannabis stock frenzy has ended and now realism has set in. Now the CGC bulls must earn the market's trust once again.

Aleafia’s Announcement Should Concern Aphria Stock Investors

By Mark Putrino, CMT
The lack of clarity regarding the Aleafia agreement is yet another reason Aphria stock holders should be concerned.

Avoid Cronos Group Stock Even After Yesterday’s Cannabis Carnage

By Faisal Humayun, InvestorPlace Contributor
Health impact of vaping makes CRON stock a concern from a regulatory and growth perspective. Keep it on the investment radar, but shares aren't likely to trend higher anytime soon.

Is Aurora Cannabis’ Growth Strategy Enough to Turn Around ACB Stock?

By Mark Putrino, CMT
Global operations and distribution are a large part of Aurora's strategy. Will it be enough to turn around the decline of ACB stock?

9 Critical Things to Watch in Marijuana Stocks

By Mark Putrino, CMT
If understood and used correctly, technical analysis of marijuana stocks can allow you to identify important levels and trends -- and profit.

Here’s How the Mandela Effect Has Hurt Cronos Group Stock

By Josh Enomoto, InvestorPlace Contributor
Hysteria over the vaping crisis has hurt CRON stock. But investors should have patience until all the facts are straightened out.

Aurora Cannabis Stock Is Down, But Not Dead

By Nicolas Chahine, InvestorPlace Contributor
As cannabis stocks have come back down to Earth, darlings like ACB stock have taken a hit. But the future for Aurora Cannabis looks bright.

Square (SQ Stock) Disrupts Yet Another Industry

By InvestorPlace Research Staff
Square is a dream come true for small business owners. And, as of Thursday, that’s now true for a whole new (and red-hot) market: cannabidiol (CBD).

Don’t Give Up on These 4 Cannabis Stocks

By Luke Lango, InvestorPlace Senior Investment Analyst
Cannabis stocks are down, but they aren't out just yet. Instead, the growth fundamentals imply tremendous long-term upside for a few names.

Investors Should Wait to Buy Canopy Growth Stock Until Profits Appear

By Mark R. Hake, CFA
Canopy Growth stock continues to falter. Its operating losses and acquisitions continue to bleed its value. Wait for profits to show up.

Hold Your Nose and Buy Canopy Growth Stock

By Wayne Duggan, InvestorPlace Contributor
CGC stock has continued to slide since a Bank of America downgrade in late September. But even the analyst that downgraded the stock admits the long-term outlook for Canopy is bullish.

I’m Recommending Canopy Growth Stock… but Not for the Reason You Think

By David Moadel, InvestorPlace Contributor
Owning CGC stock is a legalized-cannabis play, of course – but could it also be a sports-nutrition play?
Load More